Guidelines suggest the asthma component in asthma COPD overlap syndrome should be the initial treatment target,48 and a LABA alone should be avoided. Warn about oral thrush, and the increased risk for pneumonia.46 If FUNDING The authors declare that no funding was received. REFERENCES 1 Global ...
Approximately 180,000 deaths worldwide each year are attributable to asthma [2], a figure that has fallen substantially in recent decades with the introduction of guidelines for treatment that emphasise the use of inhaled steroids to control the disease [3]. Deaths from COPD however, are eight ...
while the importance of traditional cardiovascular risk factors and the optimisation of treatment for cardiovascular diseases according to their guidelines is acknowledged, here we will primarily focus on the influence
It is essential to develop a reliable pathway to ensure accurate and timely diagnosis and treatment are maintained for the future. Tools, guidelines, and ongoing education and support can help sustain this. NHS Improvement acknowledges the contribution of project teams from Mansfield and Ashfield CCG...
Studies on the pathology of COPD bronchi have contributed significantly to our current knowledge, but an important limitation, particularly those in patients with severe disease, is a potential effect of steroid treatment. Although not generally a problem with peripheral airway samples obtained by lung...
Future research could investigate the respective treatment profile relative to paroxysmal AF and to persistent AF [47] to confirm and extend our findings. Our null results for other comorbidities (i.e., depression and depressive symptoms, anxiety, BMI, CKD, and type-II diabetes) goes against ...
This randomized clinical trial compares the effects of adding theophylline vs placebo to inhaled corticosteroids (ICS) treatment on prevention of
Further research is also needed to understand the clinical implications and long-term outcomes of pursuing standard treatment for COPD in the LLN−/FR+ group. The burden of respiratory symptoms was generally lower in this group compared with those with airflow obstruction by LLN. This may ...
Inhaled therapies have been the mainstay of treatment for patients with COPD for more than a decade. They provide symptomatic relief, and long-acting bronchodilators can reduce exacerbation rates and hospitalisation. NICE produced an easy to follow algorithm for prescribing. The guidelines are based ...
National Asthma and COPD Audit Programme and the NHS Long Term Plan. Lancet Respir Med. 2019;7 (10):841. doi:10.1016/S2213-2600(19)30258-9 39. NHS Wales. Health in wales: chronic obstructive pulmonary disease; 2018. Available from: https://awttc.nhs.wales/files/guidelines-and-pils/...